Hallikainen M

References (3)

Title : Tolerability of ORM-12741 and effects on episodic memory in patients with Alzheimer's disease - Rinne_2017_Alzheimers.Dement.(N.Y)_3_1
Author(s) : Rinne JO , Wesnes K , Cummings JL , Hakulinen P , Hallikainen M , Hanninen J , Murphy M , Riordan H , Scheinin M , Soininen H , Rouru J
Ref : Alzheimers Dement (N Y) , 3 :1 , 2017
Abstract : Rinne_2017_Alzheimers.Dement.(N.Y)_3_1
ESTHER : Rinne_2017_Alzheimers.Dement.(N.Y)_3_1
PubMedSearch : Rinne_2017_Alzheimers.Dement.(N.Y)_3_1
PubMedID: 29067315

Title : Use of Anti-Dementia Drugs in Relation to Change in Cognition, Behavior, and Functioning in Alzheimer's Disease over a Three-Year Period: Kuopio ALSOVA Study - Tormalehto_2015_J.Alzheimers.Dis_48_1033
Author(s) : Tormalehto SM , Martikainen JA , Vaatainen ST , Hallikainen IT , Hallikainen M , Bell JS , Koivisto AM
Ref : J Alzheimers Dis , 48 :1033 , 2015
Abstract : Tormalehto_2015_J.Alzheimers.Dis_48_1033
ESTHER : Tormalehto_2015_J.Alzheimers.Dis_48_1033
PubMedSearch : Tormalehto_2015_J.Alzheimers.Dis_48_1033
PubMedID: 26444756

Title : Tetrahydroaminoacridine modulates technetium-99m labelled ethylene dicysteinate retention in Alzheimer's disease measured with single photon emission computed tomography imaging - Riekkinen_1995_Neurosci.Lett_195_53
Author(s) : Riekkinen P, Jr. , Kuikka J , Soininen H , Helkala EL , Hallikainen M , Riekkinen P
Ref : Neuroscience Letters , 195 :53 , 1995
Abstract : Riekkinen_1995_Neurosci.Lett_195_53
ESTHER : Riekkinen_1995_Neurosci.Lett_195_53
PubMedSearch : Riekkinen_1995_Neurosci.Lett_195_53
PubMedID: 7478254